On Queen Street: Pharmaceutical advocacy group rebrands; Rob Silver leaves Crestview

IMC3
Canada's Research-Based Pharmaceutical Companies is now Innovative Medicines Canada following 'serious issues' and concerns about branding.
Marco Vigliotti | January 5, 2016
This content is available to lobbymonitor.ca subscribers.

Already a subscriber?

Sign in here
The Lobby Monitor community is passionate, plugged-in and engaged in Canadian politics and policy.
Come inside the bubble. Take a free trial today.
Free Trial
Subscribe
Unlimited access to lobbymonitor.ca and our exclusive newsletters. Free trial